U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT07447154) titled 'GenesiDol for the Management of Musculoskeletal Pain' on Dec. 22, 2025.
Brief Summary: Inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis, are chronic, relapsing conditions characterized by persistent inflammation of the gastrointestinal tract and a significant impact on patients' quality of life. Crohn's disease can involve any part of the gastrointestinal tract, most commonly the terminal ileum and colon, whereas ulcerative colitis is confined to the colonic mucosa. Typical symptoms include abdominal pain, diarrhea, fatigue, fever, and weight loss, often alternating between periods of remission and...